Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients

Inclusion criteria: * Mild to moderate persistent asthma for at least 6 months. Exclusion criteria: * Past or recent history of significant medical illness and/or lab abnormalities including but not limited to ECG abnormalities, abnormal LFT, HIV, Hep B/C, * Allergic disorders, pancreatic disease, serious underlying respiratory diseases, life threatening asthma, renal disease etc * Surgical and/or medical conditions which significantly effect ADME of the drug. * Prior use of asthma medications (except SABA's) prior to 2 weeks of dosing Other protocol-defined inclusion/exclusion criteria may apply